Close Menu

    Subscribe to Updates

    Get the latest news information from worldwide businesses.

    What's Hot

    Thai FDA approves new treatment for gonorrhoea

    July 28, 2026

    Placenta Accreta Spectrum Risk Climbs With Rising C-Sections

    July 28, 2026

    SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases

    July 28, 2026
    Facebook Instagram YouTube LinkedIn X (Twitter)
    Trending
    • Thai FDA approves new treatment for gonorrhoea
    • Placenta Accreta Spectrum Risk Climbs With Rising C-Sections
    • SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases
    • US begins review of its military presence in Europe
    • 39 Amarnath Yatra pilgrims hurt as bus falls into gorge in J-K
    • U.S. Consulate in Toronto fired upon for the second time this year
    • MHT CET 2026 Final merit list released at fe2026.mahacet.org; check steps to download | Education News
    • 4-time WWE champion comes out of retirement after 3 years just before SummerSlam 2026
    Newspublicly
    • About Us
    • Advertise & Partner with us
    • Pitch Your Story
    • Contact Us
    Facebook Instagram LinkedIn X (Twitter)
    Subscribe
    • Home
    • World News
      • Asia
      • India
      • USA
      • UK & Europe
      • Middle East
    • Economy & Business
      • Global Economy
      • Corporate & Industry
      • Finance & Markets
      • Policy & Trade
    • Technology
      • Gadgets & Devices
      • Software & Apps
      • AI & Machine Learning
      • Robotics & Automation
    • Health & Medicine
      • Fitness & Nutrition
      • Research & Innovation
      • Disease & Treatment
      • Doctors, Clinics & Patient Care
    • Travel & Tourism
    • Automobile
      • Electric & Hybrid Vehicles
      • Auto Industry Insights
    • Sports
    • More
      • Education
      • Real Estate
      • Environment & Climate
      • Space & Astronomy
      • War & Conflicts
    Newspublicly
    Home»Health & Medicine»Doctors, Clinics & Patient Care»India’s Plan to Eliminate Hepatitis as a Public Health Threat by 2030
    Doctors, Clinics & Patient Care

    India’s Plan to Eliminate Hepatitis as a Public Health Threat by 2030

    AdminBy AdminJuly 28, 2026No Comments4 Mins Read0 Views
    Share
    Facebook Twitter LinkedIn Copy Link WhatsApp


    Can India eliminate hepatitis by 2030? More than 21 crore screenings suggest the country is making steady progress.

    India`s Plan to Eliminate Hepatitis as a Public Health Threat by 2030

    Marking World Hepatitis Day, the Indian government has laid out how it plans to eliminate hepatitis as a public health threat by 2030 — through free diagnostics, free treatment, and a healthcare network that now reaches down to the local level, not just district hospitals (1✔ ✔Trusted Source
    India’s Fight to Combat Hepatitis

    Go to source

    ).

    Advertisement

    Hepatitis Types

    Hepatitis is inflammation of the liver, caused by viral infection or toxic substances like alcohol and drugs, or autoimmune disease. There are five main hepatitis viruses: A, B, C, D and E — of which Hepatitis B and C are the most common and can lead to chronic disease including cirrhosis (fibrosis of liver tissue) and liver cancer mj .

    Advertisement

    The Scale of the Problem in India

    The World Health Organization estimated viral hepatitis caused around 1.34 million deaths globally in 2015. According to the National Viral Hepatitis Control Programme (NVHCP), India is estimated to have around 40 million people living with Hepatitis B and 6-12 million with Hepatitis C (2✔ ✔Trusted Source
    National Viral Hepatitis Control Program

    Go to source

    ).

    More recent government surveillance data offers a clearer local picture: in India’s 2021 HIV Sentinel Surveillance survey, about 0.85% of people tested positive for Hepatitis B i.e. 1 in 118 people and 0.29% for Hepatitis C i.e. 1 in 345 people

    Advertisement

    The Numbers So Far: How Far Has India Come?

    The numbers so far reflect real scale where 21.06 crore beneficiaries have been screened under this programme, with roughly 6.12 lakh Hepatitis B and C patients having received treatment. This care is now delivered across 1,153 treatment sites nationwide (3✔ ✔Trusted Source
    India steps up efforts to eliminate hepatitis as a public health threat by 2030

    Go to source

    ).

    How the Government Plans to Get There by 2030

    India launched the National Viral Hepatitis Control Programme (NVHCP) in 2018, aligned with the United Nations’ Sustainable Development Goal to end hepatitis epidemics by 2030. The programme’s approach rests on three pillars: prevention, diagnosis and treatment, and monitoring.

    To prevent new infections, the Hepatitis B vaccine is included in India’s Universal Immunisation Programme. Newborns receive a birth dose within 24 hours of delivery, followed by additional doses at 6, 10, and 14 weeks. Pregnant women are also routinely screened for Hepatitis B, allowing babies at risk to receive hepatitis B immunoglobulin (HBIG) along with the vaccine for added protection.

    On treatment, free diagnostics and medicines are available for Hepatitis B and C at government facilities nationwide. Hepatitis C, notably, has no vaccine — but can now be cured in 12-24 weeks in nearly all patients using modern antiviral drugs.

    The programme also links with India’s other major health missions — screening high-risk groups through the National AIDS Control Programme, using existing TB-testing machines for molecular diagnosis, and tracing Hepatitis-positive blood donors for follow-up care through blood transfusion services.

    Bringing Care Closer to Patients

    Hepatitis care is now moving from district hospitals down to local health centers, reducing how far patients need to travel for testing and treatment. The programme also runs a dedicated toll-free helpline — 1800-11-6666 — offering information on prevention, transmission, and where to access care.

    Officials describe the approach as using smarter local funding and cheaper generic drugs to stretch resources further, expanding the reach of free care without waiting for new budget allocations.

    Since the programme launched in 2018, India has steadily expanded free hepatitis screening and treatment nationwide — stretching resources further through smarter local funding and lower-cost generic drugs. Care that once required a trip to a district hospital is now increasingly available at the local health centre instead. It’s a shift that echoes the government’s broader vision of Sabka Saath, Sabka Vikas.

    References:

    1. India’s Fight to Combat Hepatitis
      – (https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=159330&ModuleId=3®=48&lang=2)
    2. National Viral Hepatitis Control Program
      – (https://nvhcp.mohfw.gov.in/about_us)
    3. India steps up efforts to eliminate hepatitis as a public health threat by 2030 – (https://newsonair.gov.in/india-steps-up-efforts-to-eliminate-hepatitis-as-a-public-health-threat-by-2030/)

    Source-Medindia



    Source link

    Author

    • Admin

      NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Admin
    • Website

    NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Related Posts

    Placenta Accreta Spectrum Risk Climbs With Rising C-Sections

    July 28, 2026

    Can Albertans Get an MRI Without a Doctor’s Referral?

    July 28, 2026

    The Hidden Costs of Patient Empowerment in Chronic Illness

    July 28, 2026
    Leave A Reply Cancel Reply

    Demo
    Top Posts

    The Blue Moon rises on May 30— Where and when to see the second full moon of the month

    May 30, 202640 Views

    New SOCOM rifle allows barrel swapping and cartridge changes

    June 1, 202633 Views

    “Inside Gemini Robotics 1.5: How Robots Learn to Reason & Act

    November 22, 202527 Views

    525 pounds of cocaine seized after Nebraska K9 alerts troopers on I-80

    May 28, 202624 Views
    Don't Miss

    Thai FDA approves new treatment for gonorrhoea

    July 28, 20262 Mins Read0 Views

    Thailand’s Food and Drug Administration has approved Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for the…

    Placenta Accreta Spectrum Risk Climbs With Rising C-Sections

    July 28, 2026

    SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases

    July 28, 2026

    US begins review of its military presence in Europe

    July 28, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
    • WhatsApp

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Demo
    NEWSPUBLICLY
    Facebook X (Twitter) Instagram LinkedIn

    Home

    • About Us
    • Leadership
    • Advertise & Partner With Us
    • Pitch Your Story
    • Media Kit & Pricing
    • Career
    • FAQs

    Guidelines

    • Editorial & Submission
    • Partnership
    • Advertising & Sponsor
    • Intellectual Property Policy
    • Community & Comment
    • Security & Data Protection
    • Send Your Opinion

    Quick Links

    • Cookie Policy
    • Payment & Billing Terms
    • Refund & Cancellation
    • Copyright Policy
    • Complaint & Support
    • Sitemap
    • Contact Us

    Subscribe Us

    Get the latest news and updates!

    Copyright © 2026 Newspublicly (DIGITALIX COMMUNICATION). All Rights Reserved.
    • Privacy Policy
    • Terms of Use
    • Disclaimer